High Purity Schizophrenia Treatment Antipsychotic Olanzapine Raw Powder CAS 132539-06-1

• Powder: Yes
• Customized: Customized
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Solid
• Purity: >98%
• Model NO.: Antipsychotic Olanzapine
• Product Name: Olanzapine
• CAS No.: 132539-06-1
• Molecular Formula: C17h20n4s
• Molecular Weight: 312.43
• Melting Point: 195°c
• Boiling Point: 476.0±55.0 °c(Predicted)
• Density: 1.32±0.1 g/cm3(Predicted)
• Transport Package: Foil Bag
• Specification: 1kg /bag
• Trademark: SENWAYER
• Origin: China
• HS Code: 29333990
• Production Capacity: 2000kg/Month

Product Description

 High Purity Schizophrenia Treatment  Antipsychotic Olanzapine Raw Powder CAS 132539-06-1 

Product name	Olanzapine
CAS number	132539-06-1
Molecular formula	C17H20N4S
Molecular weight	312.43

Appearance	White Powder
Purity	99.0%
Description	Olanzapine (originally branded Zyprexa) is an atypical antipsychotic. It is approved by the U.S. Food and Drug Administration (FDA) for the treatment of schizophrenia and bipolar disorder. Olanzapine is structurally similar to clozapine and quetiapine, but is classified as a thienobenzodiazepine. The olanzapine formulations are manufactured and marketed by the pharmaceutical company Eli Lilly and Company; the drug went generic in 2011. Sales of Zyprexa in 2008 were $2.2B in the US, and $4.7B worldwide.
Function	Olanzapine also known as olanzapine, olanzapine Oran, is a common antipsychotic drugs, clinically used to control schizophrenia, bipolar mania and agitation symptoms of dementia, it can significantly improve schizophrenia negative (for example: apathy, emotional and social withdrawal, poverty of speech), positive symptoms (such as: delusions, hallucinations, thought disorder, hostility and suspicion), and it may also relieve common secondary schizophrenia and related disorders affective symptoms. Good oral absorption, it needs 5-8 hours to reach the peak plasma concentration, and it is not affected by eating, it is metabolized in the liver through a combination of oxidation ; the major circulating metabolite is the 10-N-glucuronide.

 

Oral formulation: acute and maintenance treatment of schizophrenia in adults, acute treatment of manic or mixed episodes associated with bipolar I disorder (monotherapy and in combination with lithium or valproate)
Intramuscular formulation like Zyprexa IntraMuscular: acute agitation associated with schizophrenia and bipolar I mania in adults Oral formulation combined with fluoxetine: treatment of acute depressive episodes associated with bipolar I disorder in adults, or treatment of acute, resistant depression in adults .